Study to Evaluate the Safety and Immunogenicity of Investigational Vaccines Using the RSV (Respiratory Syncytial Virus) Monovalent Antigen in Healthy Participants 18 to 49 Years of Age
Clinical trial NCT07071558 · COMPLETED
Trial details
- NCT number
- NCT07071558
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-14
- Primary completion
- 2026-03-17
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.